MLICM
PRVL

Metropolitan Life Insurance Company (MetLife)’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,697
Closed -$108K – 2620
2020
Q4 		$108K Buy
+4,697
New +$108K ﹤0.01% 2321
2020
Q3 		– Sell
-5,055
Closed -$75.3K – 2607
2020
Q2 		$75.3K Hold
5,055
– – ﹤0.01% 2409
2020
Q1 		$61.6K Buy
+5,055
New +$61.6K ﹤0.01% 2315